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Abstract 
Background: Chronic obstructive pulmonary disease (COPD) and coronary 
artery disease (CAD) co-morbidity exists at different rates.  This co-morbidity 
affects quality of life and increases mortality.  In the developing world the 
prevalence of CAD is increasing but the prevalence of COPD is unknown.  
This study was designed to estimate the proportion of patients with CAD who 
have concomitant COPD and identify factors that may increase the likelihood 
of COPD in CAD patients. 
Methods:  A cross sectional study that included consecutive adults with 
catheter diagnosed CAD recruited from two cardiac centers.  Patients completed a COPD diagnosis 
validated questionnaire and performed spirometry using an electronic spirometer.  COPD was 
diagnosed if patient score placed him/her in the high likelihood zone of having COPD, or if the 
FEV1 was less than 80 % predicted.  Results were compared using chi-square test. 
Results:  Fifty nine patients with CAD were studied.  The mean age (SD) was 59 (9.7) years.  Of 
these 59 patients; 27 (44%) had COPD diagnosed by either questionnaire or spirometry.  COPD 
was significantly more among patients with single vessel disease compared with multiple vessel 
disease  
(p = 0.01).  There was no difference in the number of smokers among patients with CAD and 
COPD, and CAD alone (p = 0.29).  The prevalence of COPD increased with increasing age 
(p=0.003).   
Conclusion: In this group of patients with CAD more than two in five have concomitant COPD.  
The prevalence of COPD increases with age and is more in patients with single vessel disease 
compared with patients who have multiple vessel disease. 
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any studies have shown that 
chronic obstructive pulmonary 
disease (COPD) and coronary 
artery disease (CAD) co-morbidity exists at 
different rates specially that they share a 
common risk factor namely cigarette 
smoking.1-4  
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COPD and CAD co-morbidity affects health 
related quality of life, medication choice, 
morbidity and increases mortality.1-3  Also, 
COPD has been shown to be an independent 
cardiovascular risk factor in many reports,5-7 
and the incidence of CAD has been shown to 
be directly related to progressive FEV1 
worsening.6  There is growing evidence that 
COPD is associated with a systemic 
inflammatory component, the intensity of 
which relates to the severity of the underlying 
disease.5  It is conceivable that this systemic 
inflammatory component may exacerbate the 
inflammatory process that is associated with 
atherosclerosis and atherothrombosis.5   
M
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 The incidence and prevalence of CAD 
are increasing in the developing world; it is 
projected that worldwide CAD mortality rates 
will double from 1990 to 2020, with 
approximately 80% of the increase 
attributable to the developing world.8  
Existing data suggest that rapid 
socioeconomic growth in developing 
countries is increasing exposure to risk factors 
for CAD, such as diabetes, 
hypercholesterolemia, hypertension, and 
smoking.8,9  In the developed world COPD 
affects more than one in twenty of the adult 
population and over the next few years COPD 
is projected to be the third leading cause of 
death.10,11  Epidemiology data of COPD in the 
developing word are very sparse; in fact there 
is hardly any published work in relation to 
this.  This study was carried out to estimate 
the proportion of patients with catheter 
diagnosed CAD who have concomitant 
COPD and identify risk factors for COPD and 
CAD co-morbidity in a developing world 
country – Sudan.   
 
Methods 
 This is a cross sectional study that was 
conducted during the period August 2007 to 
January 2008 inclusive.  It included all 
consecutive adults with catheter diagnosed 
CAD recruited from two cardiac centers in 
Khartoum, Sudan: Sudan Heart Centre and 
Elshaab Teaching Hospital.  Ethical approval 
for the study was obtained from the 
administrative and ethical committee of 
Sudan Heart Centre and all patients gave 
informed consent to take part in the study.  
All patients were interviewed and completed 
a COPD diagnosis validated questionnaire,12 
and a score was calculated for each patient.  A 
COPD diagnosis was assigned to all 
individuals whose total score (19.5 or more) 
placed them within the high likelihood zone 
of having obstruction in a receiver operator 
characteristic (ROC) curve; these are 
individuals with high predictive value of a  
 
 
positive result.12   Patients performed 
spirometry using an electronic spirometer: 
(Spida 5, Micromedical, England).  The 
maneuver was explained to each subject and 
the best of three readings was recorded.  
Height was measured to the nearest 
centimeter and weight was recorded to the 
nearest kilogram.  Predicted values were 
calculated as those for blacks.  Study 
diagnoses were based on guidelines 
developed by the American Thoracic Society 
and European Respiratory Society task force: 
standards for the diagnosis and treatment of 
patients with COPD.13  A study diagnosis of 
COPD was assigned to persons with FEV1 
less than 80 % predicted.13  Results were 




 A total of 59 patients with catheter 
proven CAD were studied.  The table shows 
the demographic and clinical characteristics 
of the 59 patients.  More than half were 
males.  The overall prevalence of COPD 
diagnosed by either questionnaire or 
spirometry was 44%.  All 59 patients 
completed the questionnaire; of these 20 had 
total scores that placed them within the high 
likelihood zone of having obstruction in a 
receiver operator characteristic (ROC) curve 
(scored 19.5 or more) and were labelled as 
COPD.  Of the 59 patients studied 40 
performed spirometry and of these 11 had 
FEV1 less than 80% predicted and were 
diagnosed as COPD.  Of the 59 patients with 
CAD, 29 had single vessel disease of 
whom18 were diagnosed as COPD 
significantly higher than 9 patients with 
COPD among 30 patients with multiple vessel 
disease (p = 0.013).  The total numbers of 
current or previous smokers among the 59 
patients with CAD were 22 (37%).  Of the 22 
smokers 12 were among patients with CAD 
and COPD and 10 were among patients with 
CAD alone; the difference was not 
statistically significant (p = 0.296).   
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The table:  Demographic and clinical characteristics of the 59 patients with catheter   






The figure shows the prevalence of COPD, expressed as percentage, among different age groups in 
the 59 patients with CAD.  The prevalence of COPD increased significantly with increasing age  
























         The figure:  the prevalence of COPD (expressed as percentage) among different age  
   groups in the 59 patients with CAD (p = 0.0032). 
Characteristic Number (percentage) p value 
Sex   
Male 35 (59%)  
Female 24 (41%)  
COPD diagnosed by questionnaire or spirometry 27 (44%)  
Questionnaire diagnosed COPD 20 (34%)  
Spirometry diagnosed COPD 11 (28%)  
COPD in patients with single vessel disease 18 (62%)  
  p = 0.0134 
COPD in patients with multiple vessel disease 9 (30%)  
Smokers (CAD + COPD) 12 (44%)  
  P = 0.296 
Smokers (CAD alone) 10 (31%)  
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 The present study has shown that 
more than two in five patients with CAD have 
concomitant COPD.  Prior work has 
demonstrated that CAD and COPD co-
morbidity exists at different rates.1-4 
However, these studies were either 
retrospective or were conducted in primary 
care settings where the diagnoses of CAD 
was made on clinical grounds rather than by 
angiography.3,4  The difference in prevalence 
between previous work and our study may be 
explained by the fact that the present study 
was hospital based and recruited patient with 
CAD diagnosed by cardiac catheterization.  
Moreover, the present study was conducted in 
a developing world country where the 
epidemiology of CAD and COPD are likely 
to be different compared with those of the 
developed world.  Nevertheless, the 
prevalence rate recorded in this study is high 
enough to warrant COPD screening of all 
patients with catheter proven CAD.  
Epidemiological studies have shown that the 
developing world will bear the brunt of the 
worldwide increasing incidence of CAD and 
CAD mortality.8  Given these projected 
increases in CAD the high prevalence of 
COPD co-morbidity in CAD patients shown 
in this study will have an enormous burden in 
terms of disability, mortality and health 
expenditure in developing world 
countries.1,14,15  This will be an add on to 
health budgets that are already exhausted by 
the load of treating and preventing endemic 
diseases.  
 
 For the diagnosis of COPD we used 
both a COPD diagnosis validated 
questionnaire and spirometry.  The definitive 
diagnostic maneuver for COPD is 
spiromtry.16  However, prior work has 
demonstrated that questionnaires based on 
patient-reported information can be used to 
identify individuals likely to have COPD 
among specific risk groups.12,17  The GOLD 
guidelines define an early stage of COPD – 
GOLD stage 0 – in which individuals have 
chronic respiratory symptoms without  
 
measurable airflow obstruction.16  
Furthermore, prospective long term 
population based studies focusing on early 
stage COPD in relation to respiratory disease 
years latter have shown significantly 
increased risk of developing COPD.18,19  The 
questionnaire we used adopted a simple 
scoring system to enhance practicality.12  We 
used a cut score that placed individuals in a 
zone with a high likelihood of having 
obstruction in an ROC curve - high positive 
predictive value (PPV).12  At this cut point, 
the questionnaire we used had PPV very 
comparable to other surveys that adopted the 
same approach.12  Since the questionnaire 
scoring system we used is based on positive 
and negative predictive values, which are 
sensitive to baseline prevalence, questionnaire 
performance is likely to be different in 
different populations with different rates of 
prevalence.  The questionnaire we used 
achieved high PPV at a baseline prevalence of 
COPD of 18.7%.12 Since the prevalence rates 
of COPD in CAD patients are higher than 
18.7% as shown in previous studies, 1-4 we 
expect the questionnaire to have a higher PPV 
in our subjects at the cut point we used and 
hence increase the number of individuals with 
COPD albeit the increment being small.   
 
 Our study identified two risk factors 
for COPD and CAD co-morbidity: increasing 
age and single vessel disease.  Community 
based studies showed that the prevalence of 
COPD increases with increasing age.19,20 It 
was, therefore, not surprising to find 
significantly more COPD in older patients 
with CAD.  In numerical terms the problem is 
likely to have a significant socioeconomic 
impact given the projected increase in CAD 
patients and an increasing aging population.  
It is known that patients with multiple vessels 
CAD have worse prognosis when compared 
with patients with single vessel CAD.21  Our 
study, however, showed that significantly 
more patients with CAD and COPD had 
single vessel disease than patients with CAD 
alone.  The likely explanation for this finding 
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is a selection bias in the population we 
studied.  It is known that concomitant COPD 
in CAD patients increases symptoms.1,2  The 
patients we studied are patients with CAD 
who were recruited from the catheter 
laboratory and it is very likely that they were 
symptomatic and were, therefore, investigated 
by cardiac catheterization.  However, a larger 
scale study is needed to find if concomitant 
COPD affects prognosis in patients with 
single vessel CAD. 
  
  The current study has not shown 
smoking to be a risk factor for COPD in CAD 
patients.  Smoking is a well established risk 
factor for both COPD and CAD.22-24 The 
number and percentage of smokers in patients 
with CAD alone and CAD and COPD co-
morbidity in the present study fall short of 
figures recorded in other epidemiological 
surveys.22,23  We believe that the likely 
explanation for these differences is cultural 
denial of smoking in our community 
especially among females.  This is supported 
by epidemiological studies of smoking 
conducted in communities similar to ours 
using questionnaires which showed wide 
variation in prevalence and concluded that 
social, cultural, and religious inhibitions may 
have prevented smokers from providing 
accurate information about their smoking 
habits.25-27 We, therefore, consider that the 
actual numbers of smokers among the 
population we studied is higher.  There are, 
however, two further alternative explanations 
for the low prevalence of smoking among the 
present study population that we ought to 
consider: firstly, we have not assessed the role 
of passive smoking which increases the risk 
of ischemic heart disease by about 30% and 
contributes significantly to the development 
of COPD.28,29  Hence, we can not rule out the 
possible contribution of passive smoking to 
causing COPD and CAD in our subjects.  
Secondly, it is possible that non-smoking 
related COPD, which may be more prevalent 
in developing countries,30 and risk factors 
other than smoking for CAD were important 
etiological factors in this study population.  
 
Conclusion 
 In conclusion this study has shown 
that 44% of patients with catheter proven 
CAD have concomitant COPD in a 
developing country – Sudan.  This will have 
enormous burden on health expenditure in a 
region where health budgets are already 
strained by costs of compacting endemic 
diseases.  Given the projected increases in 
incidence of CAD in this part of the world the 
problem is likely to get worse.  The 
prevalence rate we recorded warrants routine 
screening of all CAD patients for COPD 
specially those with single vessel disease and 
older individuals.  Further large scale studies 
are needed to determine future trends and 
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